Biggest changeThe timeframe for submitting new claims under the CEWS ended in May 2022, and we do not expect to qualify for further assistance under this program. 32 Table of Contents Results of Operations – Years Ended December 31, 2022, 2021 and 2020 Selected financial highlights are presented in the table below: Year Ended December 31, 2022 2021 2020 (In thousands) REVENUES: Government Operations $ 1,808,483 $ 1,725,097 $ 1,763,127 Commercial Operations 427,358 407,082 371,269 Eliminations (3,007) (8,105) (10,880) $ 2,232,834 $ 2,124,074 $ 2,123,516 OPERATING INCOME: Government Operations $ 336,501 $ 329,549 $ 345,250 Commercial Operations 27,418 35,243 36,915 $ 363,919 $ 364,792 $ 382,165 Unallocated Corporate (15,348) (18,944) (23,613) Total Operating Income $ 348,571 $ 345,848 $ 358,552 Consolidated Results of Operations Year Ended December 31, 2022 vs. 2021 Consolidated revenues increased 5.1%, or $108.8 million, to $2,232.8 million in the year ended December 31, 2022 compared to $2,124.1 million in 2021, due to increases in our Government Operations and Commercial Operations segments of $83.4 million and $20.3 million, respectively.
Biggest changeGovernment is obligated to pay substantially all the decommissioning costs. 34 Table of Contents Results of Operations – Years Ended December 31, 2023, 2022 and 2021 Selected financial highlights are presented in the table below: Year Ended December 31, 2023 2022 2021 (In thousands) REVENUES: Government Operations $ 2,031,337 $ 1,808,483 $ 1,725,097 Commercial Operations 466,344 427,358 407,082 Eliminations (1,372) (3,007) (8,105) $ 2,496,309 $ 2,232,834 $ 2,124,074 OPERATING INCOME: Government Operations $ 374,682 $ 336,501 $ 329,549 Commercial Operations 37,532 27,418 35,243 $ 412,214 $ 363,919 $ 364,792 Unallocated Corporate (29,155) (15,348) (18,944) Total Operating Income $ 383,059 $ 348,571 $ 345,848 This section discusses our 2023 and 2022 results of operations and contains year-to-year comparisons between 2023 and 2022.
We utilize our Revolving Credit Facility and a bilateral letter of credit facility to support such obligations, but the issuance of letters of credit under our bilateral letter of credit facility is at the issuer’s discretion, and our bilateral facility generally permits the issuer, in its sole discretion, to demand collateral if the issuer does not otherwise have the benefit of the collateral under our Credit Facility.
We utilize our Revolving Credit Facility and a bilateral letter of credit facility to support such obligations, but the issuance of letters of credit under our bilateral letter of credit facility is at the issuer’s discretion, and our bilateral letter of credit facility generally permits the issuer, in its sole discretion, to demand collateral if the issuer does not otherwise have the benefit of the collateral under our Credit Facility.
Under the Credit Facility, (1) if an event of default relating to bankruptcy or other insolvency events occurs with respect to the Company, all related obligations will immediately become due and payable; (2) if any other event of default exists, the lenders will be permitted to accelerate the maturity of the related obligations outstanding; and (3) if any event of default exists, the lenders will be permitted to terminate their commitments thereunder and exercise other rights and remedies, including the commencement of foreclosure or other actions against the collateral.
Under the Credit Facility, (1) if an event of default relating to bankruptcy or other insolvency events occur with respect to the Company, all related obligations will immediately become due and payable; (2) if any other event of default exists, the lenders will be permitted to accelerate the maturity of the related obligations outstanding; and (3) if any event of default exists, the lenders will be permitted to terminate their commitments thereunder and exercise other rights and remedies, including the commencement of foreclosure or other actions against the collateral.
We experienced net cash generated from operations in each of the years ended December 31, 2022, 2021 and 2020. Typically, the fourth quarter has been the period of highest cash flows from operating activities because of the timing of payments received from the U.S. Government on accounts receivable retainages and cash dividends received from our joint ventures.
We experienced net cash generated from operations in each of the years ended December 31, 2023, 2022 and 2021. Typically, the fourth quarter has been the period of highest cash flows from operating activities because of the timing of payments received from the U.S. Government on accounts receivable retainages and cash dividends received from our joint ventures.
As of December 31, 2022, we were in compliance with all covenants set forth in the 2021 Indenture and the Senior Notes due 2029. Other Arrangements We have posted surety bonds to support regulatory and contractual obligations for certain decommissioning responsibilities, projects and legal matters.
As of December 31, 2023, we were in compliance with all covenants set forth in the 2021 Indenture and the Senior Notes due 2029. Other Arrangements We have posted surety bonds to support regulatory and contractual obligations for certain decommissioning responsibilities, projects and legal matters.
We have completed our annual review of our indefinite-lived intangible assets for the year ended December 31, 2022, which indicated that we had no impairment. The fair value of our indefinite-lived intangible assets was substantially in excess of carrying value.
We have completed our annual review of our indefinite-lived intangible assets for the year ended December 31, 2023, which indicated that we had no impairment. The fair value of our indefinite-lived intangible assets was substantially in excess of carrying value.
If the carrying value of a reporting unit exceeds its fair value, an impairment charge is recorded to goodwill in the amount by which the carrying value exceeds fair value. 31 Table of Contents We completed our annual review of goodwill for each of our reporting units for the year ended December 31, 2022, which indicated that we had no impairment of goodwill.
If the carrying value of a reporting unit exceeds its fair value, an impairment charge is recorded to goodwill in the amount by which the carrying value exceeds fair value. We completed our annual review of goodwill for each of our reporting units for the year ended December 31, 2023, which indicated that we had no impairment of goodwill.
The maximum permitted leverage ratio is 4.00 to 1.00, which may be increased to 4.50 to 1.00 for up to four consecutive fiscal quarters after a material acquisition. The minimum consolidated 36 Table of Contents interest coverage ratio is 3.00 to 1.00.
The maximum permitted leverage ratio is 4.00 to 1.00, which may be increased to 4.50 to 1.00 for up to four consecutive fiscal quarters after a material acquisition. The minimum consolidated interest coverage ratio is 3.00 to 1.00.
In general, we operate in capital-intensive industries and rely on large contracts for a substantial amount of our revenues. We are currently exploring growth strategies across our segments through strategic investments and acquisitions to expand and complement our existing businesses.
In general, we operate in capital-intensive industries and rely on large contracts for a substantial amount of our revenues. We operate in two reportable segments: Government Operations and Commercial Operations. We are currently exploring growth strategies across our segments through strategic investments and acquisitions to expand and complement our existing businesses.
The following sensitivity analysis shows the impact of a 25 basis point change in the assumed discount rate and return on plan assets on our FAS pension benefit plan obligations and expense for the year ended December 31, 2022: .25% Increase .25% Decrease (In millions) Discount Rate: Effect on ongoing net periodic benefit cost (1) $ 1.3 $ (1.4) Effect on projected benefit obligation $ (23.2) $ 24.3 Return on Plan Assets: Effect on ongoing net periodic benefit cost $ (2.8) $ 2.8 (1) Excludes effect of annual mark to market adjustment.
The following sensitivity analysis shows the impact of a 25 basis point change in the assumed discount rate and return on plan assets on our FAS pension benefit plan obligations and expense for the year ended December 31, 2023: .25% Increase .25% Decrease (In millions) Discount Rate: Effect on ongoing net periodic benefit cost (1) $ 0.6 $ (0.6) Effect on projected benefit obligation $ (24.0) $ 25.1 Return on Plan Assets: Effect on ongoing net periodic benefit cost $ (2.1) $ 2.1 (1) Excludes effect of annual mark to market adjustment.
We, and certain of our subsidiaries, have jointly executed general agreements of indemnity in favor of surety underwriters relating to surety bonds those underwriters issue. As of December 31, 2022, bonds issued and outstanding under these arrangements totaled approximately $113.5 million.
We, and certain of our subsidiaries, have jointly executed general agreements of indemnity in favor of surety underwriters relating to surety bonds those underwriters issue. As of December 31, 2023, bonds issued and outstanding under these arrangements totaled approximately $114.6 million.
Pension costs calculated under CAS are utilized as the basis for recovery of pension costs on our U.S. Government contracts. For the years ended December 31, 2022, 2021 and 2020, our CAS pension costs attributed to U.S. Government contracts totaled $11.7 million, $29.0 million and $43.6 million, respectively.
Pension costs calculated under CAS are utilized as the basis for recovery of pension costs on our U.S. Government contracts. For the years ended December 31, 2023, 2022 and 2021, our CAS 32 Table of Contents pension costs attributed to U.S. Government contracts totaled $13.6 million, $11.7 million and $29.0 million, respectively.
As of December 31, 2022, the weighted-average interest rate on outstanding borrowings under our Credit Facility was 5.93%. The Credit Facility generally includes customary events of default for a secured credit facility.
As of December 31, 2023, the weighted-average interest rate on outstanding borrowings under our Credit Facility was 6.96%. The Credit Facility generally includes customary events of default for a secured credit facility.
As of December 31, 2022, letters of credit issued and outstanding under our bilateral letter of credit facility totaled approximately $34.9 million, and such letters of credit are secured by the collateral under our Credit Facility. 38 Table of Contents Other Cash, Cash Equivalents, Restricted Cash and Investments In the aggregate, our cash and cash equivalents, restricted cash and cash equivalents and investments decreased by $0.3 million to $52.9 million at December 31, 2022 from $53.1 million at December 31, 2021, primarily due to the items discussed below.
As of December 31, 2023, letters of credit issued and outstanding under our bilateral letter of credit facility totaled approximately $36.7 million, and such letters of credit are secured by the collateral under our Credit Facility. 39 Table of Contents Other Cash, Cash Equivalents, Restricted Cash and Investments In the aggregate, our cash and cash equivalents, restricted cash and cash equivalents and investments increased by $38.2 million to $91.1 million at December 31, 2023 from $52.9 million at December 31, 2022, primarily due to the items discussed below.
Cash Requirements We believe we have sufficient cash and cash equivalents and borrowing capacity, along with cash generated from operations and continued access to debt markets, to satisfy our cash requirements for the next 12 months and beyond.
Our investment portfolio consists primarily of corporate bonds and mutual funds. Cash Requirements We believe we have sufficient cash and cash equivalents and borrowing capacity, along with cash generated from operations and continued access to debt markets, to satisfy our cash requirements for the next 12 months and beyond.
Statements based on historical cost, however, do not adequately reflect the cumulative effect of increasing costs and changes in the purchasing power of the U.S. dollar, especially during times of significant and continued inflation.
Effects of Inflation and Changing Prices Our financial statements are prepared in accordance with GAAP, using historical U.S. dollar accounting ("historical cost"). Statements based on historical cost, however, do not adequately reflect the cumulative effect of increasing costs and changes in the purchasing power of the U.S. dollar, especially during times of significant and continued inflation.
We expect these heightened spending levels to decline as these capital expansion projects near completion. During the year ended December 31, 2022, we paid $81.1 million in dividends to holders of our common stock.
We expect these heightened spending levels to decline as these capital expansion projects are largely complete. During the year ended December 31, 2023, we paid $85.0 million in dividends to holders of our common stock.
Our net cash provided by financing activities increased by $104.1 million to $14.0 million in the year ended December 31, 2022, compared to cash used in financing activities of $90.1 million in the year ended December 31, 2021.
Our net cash used in financing activities increased by $183.3 million to $169.4 million in the year ended December 31, 2023, compared to cash provided by financing activities of $14.0 million in the year ended December 31, 2022.
Liquidity and Capital Resources Our overall liquidity position, which we generally define as our unrestricted cash and cash equivalents plus amounts available for borrowings under our credit facility, increased by approximately $185.1 million to $532.7 million at December 31, 2022 compared to $347.7 million at December 31, 2021, primarily attributable to the borrowing of the Term Loan, as defined below, the proceeds from which were used to repay borrowings under our Revolving Credit Facility, as defined below.
Liquidity and Capital Resources Our overall liquidity position, which we generally define as our unrestricted cash and cash equivalents plus amounts available for borrowings under our credit facility, increased by approximately $116.3 million to $649.1 million at December 31, 2023 compared to $532.7 million at December 31, 2022, primarily attributable to improvements in operating cash flows which were used, in part, to repay borrowings under our Revolving Credit Facility, as defined below.
Our net cash used in investing activities decreased by $48.4 million to $256.2 million in the year ended December 31, 2022, compared to $304.7 million in the year ended December 31, 2021.
Our net cash used in investing activities decreased by $100.6 million to $155.6 million in the year ended December 31, 2023, compared to $256.2 million in the year ended December 31, 2022.
In addition, the Credit Facility contains various restrictive covenants, including with respect to debt, liens, investments, mergers, acquisitions, dividends, equity repurchases and asset sales. As of December 31, 2022, we were in compliance with all covenants set forth in the Credit Facility.
In addition, the Credit Facility contains various restrictive covenants, including with respect to debt, liens, investments, mergers, acquisitions, dividends, equity repurchases and asset sales.
As of December 31, 2022, borrowings under our Term Loan totaled $250.0 million, borrowings and letters of credit issued under the Revolving Credit Facility totaled $250.0 million and $2.5 million, respectively, and we had $497.5 million available under the Revolving Credit Facility for borrowings and to meet letter of credit requirements.
As of December 31, 2023, borrowings under our Term Loan totaled $243.8 million, borrowings and letters of credit issued under the Revolving Credit Facility totaled $175.0 million and $1.7 million, respectively, and we had $573.3 million available under the Revolving Credit Facility for borrowings and to meet letter of credit requirements.
Outstanding loans under the Credit Facility bear interest at our option at either (1) the Term SOFR plus a credit spread adjustment of 0.10% plus a margin ranging from 1.0% to 1.75% per year or (2) the base rate plus a margin ranging from 0.0% to 0.75% per year.
As of December 31, 2023, we were in compliance with all covenants set forth in the Credit Facility. 37 Table of Contents Outstanding loans under the Credit Facility bear interest at our option at either (1) the Term SOFR plus a credit spread adjustment of 0.10% plus a margin ranging from 1.0% to 1.75% per year or (2) the base rate plus a margin ranging from 0.0% to 0.75% per year.
Our effective tax rate was 24.1% for the year ended December 31, 2022 compared to 22.6% for the year ended December 31, 2021. Our effective tax rate was 22.6% for the year ended December 31, 2021 compared to 22.9% for the year ended December 31, 2020.
Our effective tax rate was 23.4% for the year ended December 31, 2023 compared to 24.1% for the year ended December 31, 2022.
Our effective tax rates for the years ended December 31, 2022, 2021 and 2020 were higher than the U.S. corporate 35 Table of Contents income tax rate of 21% primarily due to state income taxes within the U.S. and the unfavorable rate differential associated with our Canadian earnings.
Our effective tax rates for the years ended December 31, 2023 and 2022 were higher than the U.S. corporate income tax rate of 21% primarily due to state income taxes within the U.S. and the unfavorable rate differential associated with our Canadian earnings. 36 Table of Contents See Note 5 to our consolidated financial statements included in this Report for further information on income taxes.
In addition, we anticipate cash requirements totaling approximately $1.4 million for contributions to our other postretirement benefit plans in 2023.
We expect cash requirements totaling approximately $4.4 million and $1.2 million for contributions to our pension plans and other postretirement benefit plans, respectively, in 2024.
Senior Notes due 2029 We issued $400 million aggregate principal amount of 4.125% senior notes due 2029 (the "Senior Notes due 2029") pursuant to an indenture dated April 13, 2021 (the "2021 Indenture"), among the Company, certain of our subsidiaries, as guarantors, and U.S. Bank, as trustee.
As of December 31, 2023, we were in compliance with all covenants set forth in the 2020 Indenture and the Senior Notes due 2028. 38 Table of Contents Senior Notes due 2029 We issued $400 million aggregate principal amount of 4.125% senior notes due 2029 (the "Senior Notes due 2029") pursuant to an indenture dated April 13, 2021 (the "2021 Indenture"), among the Company, certain of our subsidiaries, as guarantors, and U.S.
Critical Accounting Estimates Our financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States ("GAAP"). Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. These estimates and assumptions are affected by management's application of accounting policies.
Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. These estimates and assumptions are affected by management's application of accounting policies. We believe the following are our most critical accounting policies that we apply in the preparation of our financial statements.
Assumptions include the selection of our peer companies and use of market multiples, which could increase or decrease based on the profitability of our competitors and performance of their stock, which is often dependent on the performance of the stock market and general economy as a whole.
Assumptions include the selection of our peer companies and use of market multiples, which could increase or decrease based on the profitability of our competitors and performance of their stock, which is often dependent on the performance of the stock market and general economy as a whole. 33 Table of Contents Adverse changes in the assumptions utilized in our impairment test could cause a reduction or elimination of excess fair value over carrying value, resulting in potential recognition of impairment.
The decrease in cash used in investing activities was primarily attributable to a decrease in purchases of property, plant and equipment of $112.7 million, which was partially offset by the $47.3 million acquisition of Dynamic and Cunico as well as an $11.5 million increase in investments in equity method investees during the year ended December 31, 2022.
The decrease in cash used in investing activities was primarily attributable to a decrease in purchases of property, plant and equipment of $47.0 million and the $46.7 million acquisition of Dynamic and Cunico in the prior year. In addition, we experienced an $11.5 million decrease in investments in equity method investees.
The Senior Notes due 2029 are guaranteed by each of the Company's present and future direct and indirect wholly owned domestic subsidiaries that is a guarantor under the Credit Facility. Interest on the Senior Notes due 2029 is payable semi-annually in cash in arrears on April 15 and October 15 of each year at a rate of 4.125% per annum.
Interest on the Senior Notes due 2029 is payable semi-annually in cash in arrears on April 15 and October 15 of each year at a rate of 4.125% per annum. The Senior Notes due 2029 will mature on April 15, 2029.
Other Income (Expense) During the year ended December 31, 2022, other income (expense) decreased $83.2 million to a loss of $33.3 million compared to a gain of $49.9 million in 2021.
Other Income (Expense) During the year ended December 31, 2023, other income (expense) decreased $27.5 million to a loss of $61.7 million compared to a loss of $34.2 million in 2022.
The margin for Term SOFR and base rate loans was 1.50% and 0.50%, respectively, the letter of credit fee for financial letters of credit and performance letters of credit was 1.50% and 0.90%, respectively, and the commitment fee for the unused portion of the Revolving Credit Facility was 0.20% from the closing date through the date of our delivery of the compliance certificate for the fiscal quarter ended December 31, 2022.
Based on the total net leverage ratio applicable at December 31, 2023, the margin for Term SOFR and base rate loans was 1.50% and 0.50%, respectively, the letter of credit fee for financial letters of credit and performance letters of credit was 1.50% and 0.90%, respectively, and the commitment fee for the unused portion of the Revolving Credit Facility was 0.20%.
Although we continually strive to improve our ability to estimate our contract costs and profitability, adjustments to overall contract costs due to unforeseen events could be significant in future periods.
During the year ended December 31, 2021, no adjustment to any one contract had a material impact on our consolidated financial statements. Although we continually strive to improve our ability to estimate our contract costs and profitability, adjustments to overall contract costs due to unforeseen events could be significant in future periods.
Our cash requirements as of December 31, 2022 include the following contractual obligations: Total Less than 1 Year 1-3 Years 3-5 Years After 5 Years (In thousands) Long-term debt principal $ 1,300,000 $ 6,250 $ 18,750 $ 475,000 $ 800,000 Interest payments $ 323,482 $ 65,286 $ 115,163 $ 110,033 $ 33,000 Lease payments $ 31,078 $ 4,546 $ 6,673 $ 4,035 $ 15,824 Our contingent commitments under letters of credit and surety bonds currently outstanding expire as follows: Total Less than 1 Year 1-3 Years 3-5 Years Thereafter (In thousands) $ 151,052 $ 138,775 $ 10,992 $ 1,285 $ — 39 Table of Contents Other cash requirements include, among other things, capital expenditures, payment of dividends, repurchases of common stock, capital contributions for joint ventures and contributions to our pension and other postretirement benefit plans.
Our cash requirements as of December 31, 2023 include the following contractual obligations: Total Less than 1 Year 1-3 Years 3-5 Years After 5 Years (In thousands) Long-term debt principal $ 1,218,750 $ 6,250 $ 25,000 $ 787,500 $ 400,000 Interest payments $ 249,452 $ 59,433 $ 105,567 $ 76,202 $ 8,250 Lease payments $ 28,094 $ 4,131 $ 6,654 $ 3,736 $ 13,573 Our contingent commitments under letters of credit and surety bonds currently outstanding expire as follows: Total Less than 1 Year 1-3 Years 3-5 Years Thereafter (In thousands) $ 153,054 $ 144,231 $ 8,823 $ — $ — 40 Table of Contents Other cash requirements include, among other things, capital expenditures, payment of dividends, repurchases of common stock, capital contributions for joint ventures and contributions to our pension and other postretirement benefit plans.
We immediately recognize net actuarial gains and losses in earnings in the fourth quarter as a component of net periodic benefit cost.
Actual experience that differs from these assumptions or future changes in assumptions will affect our recognized benefit obligations and related costs. We immediately recognize net actuarial gains and losses in earnings in the fourth quarter as a component of net periodic benefit cost.
Our net cash provided by operating activities decreased by $141.3 million to $244.7 million in the year ended December 31, 2022, compared to $386.0 million in the year ended December 31, 2021.
Our net cash provided by operating activities increased by $119.0 million to $363.7 million in the year ended December 31, 2023, compared to $244.7 million in the year ended December 31, 2022. The increase in cash provided by operating activities was primarily attributable to the timing of project cash flows.
Our domestic and foreign cash and cash equivalents, restricted cash and cash equivalents and investments as of December 31, 2022 and 2021 were as follows: December 31, 2022 2021 (In thousands) Domestic $ 38,455 $ 39,128 Foreign 14,436 14,016 Total $ 52,891 $ 53,144 Our working capital increased by $89.6 million to $403.8 million at December 31, 2022 from $314.1 million at December 31, 2021, primarily attributable to the timing of project cash flows and vendor payments.
Our domestic and foreign cash and cash equivalents, restricted cash and cash equivalents and investments as of December 31, 2023 and 2022 were as follows: December 31, 2023 2022 (In thousands) Domestic $ 71,177 $ 38,455 Foreign 19,934 14,436 Total $ 91,111 $ 52,891 Our working capital increased by $39.0 million to $442.8 million at December 31, 2023 from $403.8 million at December 31, 2022, primarily attributable to increases in cash and cash equivalents resulting from improved billing and collection cycles as well as the receipt of progress payments which were partially offset by the timing of accounts payable.
Government programs, we are a significant participant in the defense industry and have not been negatively impacted by federal budget reductions to date. We believe many of our programs are well-aligned with national defense and other strategic priorities as we supply high-end equipment for submarines and aircraft carriers for the U.S.
Government Operations The revenues of our Government Operations segment are largely a function of national security spending by the U.S. Government. As a supplier of major nuclear components for certain U.S. Government programs, we are a significant participant in the defense industry and have not been negatively impacted by federal budget reductions to date.
Provision for Income Taxes Year Ended December 31, Year Ended December 31, 2022 2021 $ Change 2021 2020 $ Change (In thousands) Income before Provision for Income Taxes $ 314,377 $ 395,713 $ (81,336) $ 395,713 $ 362,172 $ 33,541 Provision for Income Taxes $ 75,757 $ 89,425 $ (13,668) $ 89,425 $ 82,976 $ 6,449 Effective Tax Rate 24.1% 22.6% 22.6% 22.9% For the year ended December 31, 2022, our provision for income taxes decreased $13.7 million to $75.8 million, while income before provision for income taxes decreased $81.3 million to $314.4 million when compared to the prior year.
Provision for Income Taxes Year Ended December 31, 2023 2022 $ Change (In thousands) Income before Provision for Income Taxes $ 321,400 $ 314,377 $ 7,023 Provision for Income Taxes $ 75,079 $ 75,757 $ (678) Effective Tax Rate 23.4% 24.1% For the year ended December 31, 2023, our provision for income taxes decreased $0.7 million to $75.1 million, while income before provision for income taxes increased $7.0 million to $321.4 million when compared to the prior year.
The amount of recoverable CAS pension costs recognized as revenue on an annual basis may differ from the amounts noted above.
The amount of recoverable CAS pension costs recognized as revenue on an annual basis may differ from the amounts noted above. See further discussion of our accounting for contracts and revenue recognition above and in Note 1 to our consolidated financial statements included in this Report.
A component of other income (expense) is net periodic benefit cost, which includes mark to market adjustments due to our immediate recognition of net actuarial gains (losses) for our pension and postretirement benefit plans.
Included in other income (expense) are components of net periodic benefit cost, which include mark to market adjustments due to our immediate recognition of net actuarial gains (losses) for our pension and postretirement benefit plans which changed to a loss of $20.9 million during the year ended December 31, 2023 compared to a gain of $4.0 million for the year ended December 31, 2022.
In April 2021, our Board of Directors authorized us to repurchase an indeterminate number of shares of our common stock up to an aggregate market value of $500 million. During the year ended December 31, 2022, we repurchased $20.0 million in shares of our common stock under this and prior share repurchase authorizations.
In April 2021, our Board of Directors authorized us to repurchase an indeterminate number of shares of our common stock up to an aggregate market value of $500 million. As of December 31, 2023, the total remaining share repurchase authorization was $397.6 million. See Item 5 of this Report for additional share repurchase information.
The increase was primarily related to continued growth in design and engineering work executed by our advanced technologies business, particularly in the defense and space markets, resulting in revenue growth of $35.4 million. 33 Table of Contents Increases in volume related to the manufacture of nuclear components for U.S.
The increase was driven by higher volume in the manufacture of nuclear components for U.S. Government programs, resulting in an increase of $100.0 million when compared to the prior year. Continued growth in design and engineering work executed by our advanced technologies business, particularly in the defense market, resulted in additional revenues of $61.6 million.
Government Operations Year Ended December 31, Year Ended December 31, 2022 2021 $ Change 2021 2020 $ Change (In thousands) Revenues $ 1,808,483 $ 1,725,097 $ 83,386 $ 1,725,097 $ 1,763,127 $ (38,030) Operating Income $ 336,501 $ 329,549 $ 6,952 $ 329,549 $ 345,250 $ (15,701) % of Revenues 18.6% 19.1% 19.1% 19.6% Year Ended December 31, 2022 vs. 2021 Revenues increased 4.8%, or $83.4 million, to $1,808.5 million in the year ended December 31, 2022 compared to $1,725.1 million in 2021.
Government Operations Year Ended December 31, 2023 2022 $ Change (In thousands) Revenues $ 2,031,337 $ 1,808,483 $ 222,854 Operating Income $ 374,682 $ 336,501 $ 38,181 % of Revenues 18.4% 18.6% Year Ended December 31, 2023 vs. 2022 Revenues increased 12.3%, or $222.9 million, to $2,031.3 million in the year ended December 31, 2023 compared to $1,808.5 million in 2022.
The nature, timing and duration of any related contracts are dependent on the demand and funding availability for such technologies. 29 Table of Contents Commercial Operations The revenues in this segment primarily depend on the demand and competitiveness of nuclear energy.
Commercial Operations The revenues in this segment primarily depend on the demand and competitiveness of nuclear energy.
The increase was primarily related to higher levels of in-plant inspection, maintenance and modification services totaling $26.2 million in addition to increases in revenues related to our nuclear fuel handling capabilities of $13.3 million. We 34 Table of Contents also experienced higher revenues in our fuel fabrication and medical radioisotopes businesses in 2021 when compared to the prior year.
The increase was primarily related to higher levels of in-plant inspection, maintenance, modification and refurbishment services of $24.1 million and an increase in revenues in our medical radioisotopes business of $14.6 million. We also experienced higher volume in our nuclear components manufacturing and fuel handling businesses. These increases were partially offset by decreased revenues in our fuel fabrication business.
We would expect to fund these opportunities with cash generated from operations or by raising additional capital through debt, equity or some combination thereof. We operate in two reportable segments: Government Operations and Commercial Operations.
We would expect to fund these opportunities with cash generated from operations or by raising additional capital through debt, equity or some combination thereof. Outlook We expect to recognize approximately 51% of the revenue associated with our backlog by the end of 2024, with the remainder to be recognized thereafter.
Commercial Operations Year Ended December 31, Year Ended December 31, 2022 2021 $ Change 2021 2020 $ Change (In thousands) Revenues $ 427,358 $ 407,082 $ 20,276 $ 407,082 $ 371,269 $ 35,813 Operating Income $ 27,418 $ 35,243 $ (7,825) $ 35,243 $ 36,915 $ (1,672) % of Revenues 6.4% 8.7% 8.7% 9.9% Year Ended December 31, 2022 vs. 2021 Revenues increased 5.0%, or $20.3 million, to $427.4 million in the year ended December 31, 2022 compared to $407.1 million in 2021.
The increase was due to the operating income impact of the changes in revenues noted above. 35 Table of Contents Commercial Operations Year Ended December 31, 2023 2022 $ Change (In thousands) Revenues $ 466,344 $ 427,358 $ 38,986 Operating Income $ 37,532 $ 27,418 $ 10,114 % of Revenues 8.0% 6.4% Year Ended December 31, 2023 vs. 2022 Revenues increased 9.1%, or $39.0 million, to $466.3 million in the year ended December 31, 2023 compared to $427.4 million in 2022.
Our Commercial Operations segment's offerings also include medical radioisotope products, radiopharmaceuticals and medical devices for use in diagnostic imaging and radiotherapeutic treatments. The medical isotope business will be the platform from which we plan to launch our Molybdenum-99 product line and a number of future radioisotope-based imaging, diagnostic and therapeutic products.
The medical isotope business will be the platform from which we plan to launch our Molybdenum-99 product line and a number of future radioisotope-based imaging, diagnostic and therapeutic products. 31 Table of Contents Critical Accounting Estimates Our financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States ("GAAP").
Consolidated operating income increased $2.7 million to $348.6 million in the year ended December 31, 2022 compared to $345.8 million in 2021. Operating income in our Government Operations segment increased $7.0 million, and we also experienced lower Unallocated Corporate expenses of $3.6 million.
Consolidated operating income increased $34.5 million to $383.1 million in the year ended December 31, 2023 compared to $348.6 million in 2022. Operating income in our Government Operations and Commercial Operations segments increased $38.2 million and $10.1 million, respectively. These increases were partially offset by higher Unallocated Corporate expenses of $13.8 million.
These decreases were partially offset by an increase in restructuring related costs and higher levels of legal and consulting costs associated with due diligence activities when compared to the prior year.
During 2023, we undertook several initiatives to transform our current information technology infrastructure which resulted in an increase in expense of $2.1 million. These increases were partially offset by a decrease in legal and consulting costs associated with due diligence activities when compared to the prior year.
A portion of this segment's operations is also conducted through joint ventures, which typically earn fees, and we account for them following the equity method of accounting. See Note 4 to our consolidated financial statements included in this Report for financial information on our equity method investments. This segment also specializes in the development of advanced technologies.
See Note 4 to our consolidated financial statements included in this Report for financial information on our equity method investments. This segment also specializes in the development of advanced technologies. The nature, timing and duration of any related contracts are dependent on the demand and funding availability for such technologies.
This increase was partially offset by a reduction in net borrowings of long-term debt of $225.0 million when compared to the prior year. At December 31, 2022, we had short-term and long-term investments with a fair value of $11.9 million. Our investment portfolio consists primarily of U.S. Government securities, corporate bonds and mutual funds.
The increase in cash used in financing activities was primarily attributable to a reduction in net borrowings of long-term debt of $181.3 million which was partially offset by a reduction in repurchases of common stock of $20.0 million. At December 31, 2023, we had long-term investments with a fair value of $9.5 million.
Unallocated Corporate Unallocated corporate expenses decreased $3.6 million to $15.3 million in the year ended December 31, 2022 compared to $18.9 million in 2021, primarily due to a decrease in healthcare costs and lower compensation related expense inclusive of stock-based compensation.
Unallocated Corporate Unallocated Corporate expenses increased $13.8 million to $29.2 million in the year ended December 31, 2023 compared to $15.3 million in 2022. The increase was primarily due to increases in healthcare costs totaling $8.7 million in addition to higher compensation related expenses.
Year Ended December 31, 2021 vs. 2020 Consolidated revenues increased slightly to $2,124.1 million in the year ended December 31, 2021 compared to $2,123.5 million in 2020, due to an increase in our Commercial Operations segment of $35.8 million which was partially offset by a decrease in revenues in our Government Operations segment of $38.0 million.
Consolidated Results of Operations Year Ended December 31, 2023 vs. 2022 Consolidated revenues increased 11.8%, or $263.5 million, to $2,496.3 million in the year ended December 31, 2023 compared to $2,232.8 million in 2022, due to increases in revenues in our Government Operations and Commercial Operations segments of $222.9 million and $39.0 million, respectively.
Navy and participate in the continuing cleanup, operation and management of critical government-owned nuclear sites, laboratories and manufacturing complexes maintained by the DOE, NASA and other federal agencies. However, it is possible that reductions in federal government spending could have an adverse impact on the operating results and cash flows of this segment in the future.
However, it is possible that reductions in federal government spending could have an adverse impact on the operating results and cash flows of this segment in the future. A portion of this segment's operations is also conducted through joint ventures, which typically earn fees, and we account for them following the equity method of accounting.
The decrease was due to the operating income impact of the changes in revenues noted above as well as lower levels of net favorable contract adjustments recorded in 2021 when compared to the prior year. These decreases were partially offset by an increase in operating income of $4.5 million associated with our joint venture activities.
Operating income increased $10.1 million to $37.5 million in the year ended December 31, 2023 compared to $27.4 million in 2022. The increase was primarily due to the operating income impact of the changes in revenues noted above in addition to lower restructuring-related expenses when compared to the prior year.
Net periodic benefit cost resulted in a decrease to other income of $88.9 million in 2022 when compared to the prior year, caused by increased losses related to mark to market adjustments totaling $86.2 million.
This was caused by a decrease in pension income of $40.6 million which was partially offset by a decrease in losses related to mark to market adjustments totaling $15.8 million.